1. Home
  2. IVVD vs PITA Comparison

IVVD vs PITA Comparison

Compare IVVD & PITA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • PITA
  • Stock Information
  • Founded
  • IVVD 2020
  • PITA 2023
  • Country
  • IVVD United States
  • PITA Germany
  • Employees
  • IVVD N/A
  • PITA N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • PITA
  • Sector
  • IVVD Health Care
  • PITA
  • Exchange
  • IVVD Nasdaq
  • PITA NYSE
  • Market Cap
  • IVVD 66.6M
  • PITA 59.4M
  • IPO Year
  • IVVD 2021
  • PITA N/A
  • Fundamental
  • Price
  • IVVD $0.38
  • PITA $0.88
  • Analyst Decision
  • IVVD Strong Buy
  • PITA
  • Analyst Count
  • IVVD 4
  • PITA 0
  • Target Price
  • IVVD $7.89
  • PITA N/A
  • AVG Volume (30 Days)
  • IVVD 1.7M
  • PITA 61.9K
  • Earning Date
  • IVVD 11-14-2024
  • PITA 01-01-0001
  • Dividend Yield
  • IVVD N/A
  • PITA N/A
  • EPS Growth
  • IVVD N/A
  • PITA N/A
  • EPS
  • IVVD N/A
  • PITA N/A
  • Revenue
  • IVVD $11,564,000.00
  • PITA N/A
  • Revenue This Year
  • IVVD N/A
  • PITA N/A
  • Revenue Next Year
  • IVVD $468.95
  • PITA N/A
  • P/E Ratio
  • IVVD N/A
  • PITA N/A
  • Revenue Growth
  • IVVD N/A
  • PITA N/A
  • 52 Week Low
  • IVVD $0.38
  • PITA $0.85
  • 52 Week High
  • IVVD $5.20
  • PITA $15.00
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 40.28
  • PITA N/A
  • Support Level
  • IVVD $0.41
  • PITA N/A
  • Resistance Level
  • IVVD $0.50
  • PITA N/A
  • Average True Range (ATR)
  • IVVD 0.05
  • PITA 0.00
  • MACD
  • IVVD 0.00
  • PITA 0.00
  • Stochastic Oscillator
  • IVVD 11.50
  • PITA 0.00

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About PITA HERAMBA ELECTRIC PLC

Heramba Electric PLC provides electric mobility products and solutions for rail vehicles and buses. It offers its services to public transport companies, fleet operators and vehicle manufacturers as a solution designer and system integrator of electrical systems for rail vehicle systems (including trams, light rail vehicles, metros, regional trains and locomotives) and electrical vehicle systems (including electric buses, such as pure electric In Motion Charging trolley buses and battery electric buses). As an electrical engineering specialist, the Company supplies urban operators and rail vehicle and bus manufacturers with electrical systems for ecologically sustainable and emission-free public transportation solutions.

Share on Social Networks: